🏥Toyota Tsusho、Entry into the Subcontracted Clinical Laboratory Business in Indonesia through Joint Venture with Southeast Asia’s Largest Pharmaceutical Manufacturer

By disease, medical service

🏥Toyota Tsusho、Entry into the Subcontracted Clinical Laboratory Business in Indonesia through Joint Venture with Southeast Asia’s Largest Pharmaceutical Manufacturer
-Contributing to Early Detection and Treatment of Diseases through the First Clinical Laboratory Cen-

2018-01-18
Health Sciences Research Institute, Inc. (HSRI) and Toyota Tsusho Corporation (TTC) have established, together with Indonesian healthcare conglomerate and Southeast Asia’s largest pharmaceutical manufacturer PT. Kalbe Farma Tbk (Kalbe), a joint venture company, PT Innolab Sains Internasional (ISI), to provide subcontracted clinical laboratory services. Operations have begun at KALGen Innolab Clinical Laboratory, Indonesia’s first clinical laboratory center operated with foreign investment.

http://www.toyota-tsusho.com/press/detail/180118_004102.html

More from tokioX :

  1. iPS therapy: Keio Univ, iPS cells treated with spinal cord injury – 200000 patients in Japan
  2. Rubella Patients in Japan Up 18-Fold
  3. Animal welfare: Hokkaido ranch, cataract bear “Novita” surgery -restoration of sight in 10 years
  4. Women Everywhere Don’t Know Enough About Ovarian Cancer
  5. 💊Hokkaido University: Elucidation of proteins that hold the key to invasion of influenza virus
  6. FUJIFILM INITIATES A PHASE I CLINICAL TRIAL OF ANTI-CANCER DRUG FF-10101 IN THE UNITED STATES IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
  7. Japan 5-Year Cancer Survival Rate at 65.2 Pct .